Lawrence Knopf
2021
In 2021, Lawrence Knopf earned a total compensation of $1M as General Counsel at SQZ Biotechnologies Co, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $124,236 |
|---|---|
| Option Awards | $527,657 |
| Salary | $345,100 |
| Other | $8,700 |
| Total | $1,005,693 |
Knopf received $527.7K in option awards, accounting for 52% of the total pay in 2021.
Knopf also received $124.2K in non-equity incentive plan, $345.1K in salary and $8.7K in other compensation.
Rankings
In 2021, Lawrence Knopf's compensation ranked 8,775th out of 12,415 executives tracked by ExecPay. In other words, Knopf earned more than 29.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,775 out of 12,415 | 29th |
Division Manufacturing | 3,892 out of 5,505 | 29th |
Major group Chemicals And Allied Products | 1,718 out of 2,375 | 28th |
Industry group Drugs | 1,528 out of 2,096 | 27th |
Industry Biological Products, Except Diagnostic Substances | 334 out of 449 | 26th |
Source: SEC filing on April 26, 2023.
Knopf's colleagues
We found three more compensation records of executives who worked with Lawrence Knopf at SQZ Biotechnologies Co in 2021.